James H. Fischer

3.3k total citations
69 papers, 1.4k citations indexed

About

James H. Fischer is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, James H. Fischer has authored 69 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pediatrics, Perinatology and Child Health, 19 papers in Psychiatry and Mental health and 11 papers in Pharmacology. Recurrent topics in James H. Fischer's work include Pharmacological Effects and Toxicity Studies (20 papers), Epilepsy research and treatment (18 papers) and Pharmaceutical studies and practices (12 papers). James H. Fischer is often cited by papers focused on Pharmacological Effects and Toxicity Studies (20 papers), Epilepsy research and treatment (18 papers) and Pharmaceutical studies and practices (12 papers). James H. Fischer collaborates with scholars based in United States, Belgium and Italy. James H. Fischer's co-authors include Robert L. Kriel, P Fischer, James C. Cloyd, Hyunyoung Jeong, Donna M. Kraus, Michael Cwik, Kyunghee Yang, Huiqing Chen, Hyun Young Jeong and Jaewoo Song and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and CHEST Journal.

In The Last Decade

James H. Fischer

67 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James H. Fischer United States 22 744 501 220 175 152 69 1.4k
John H. Cavanaugh United States 23 351 0.5× 256 0.5× 81 0.4× 143 0.8× 222 1.5× 59 1.7k
Kathleen D. Lake United States 23 219 0.3× 214 0.4× 255 1.2× 172 1.0× 263 1.7× 66 2.0k
Alfonso Carvajal Spain 20 251 0.3× 140 0.3× 222 1.0× 94 0.5× 237 1.6× 63 1.6k
Daniel M. Canafax United States 26 308 0.4× 187 0.4× 384 1.7× 149 0.9× 302 2.0× 86 2.5k
Gary J. Muirhead United Kingdom 17 204 0.3× 639 1.3× 130 0.6× 130 0.7× 121 0.8× 25 1.7k
Gary L. Lensmeyer United States 20 360 0.5× 164 0.3× 91 0.4× 100 0.6× 172 1.1× 37 1.6k
Walter K. Kraft United States 29 646 0.9× 86 0.2× 371 1.7× 189 1.1× 161 1.1× 128 2.5k
Gideon Koren Canada 21 612 0.8× 134 0.3× 484 2.2× 133 0.8× 60 0.4× 39 1.6k
E Hvidberg Denmark 19 271 0.4× 210 0.4× 139 0.6× 174 1.0× 168 1.1× 68 1.4k
María José García Sánchez Spain 20 341 0.5× 211 0.4× 56 0.3× 186 1.1× 245 1.6× 74 1.2k

Countries citing papers authored by James H. Fischer

Since Specialization
Citations

This map shows the geographic impact of James H. Fischer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James H. Fischer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James H. Fischer more than expected).

Fields of papers citing papers by James H. Fischer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James H. Fischer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James H. Fischer. The network helps show where James H. Fischer may publish in the future.

Co-authorship network of co-authors of James H. Fischer

This figure shows the co-authorship network connecting the top 25 collaborators of James H. Fischer. A scholar is included among the top collaborators of James H. Fischer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James H. Fischer. James H. Fischer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holdhoff, Matthias, M. Kelly Nicholas, Richard A. Peterson, et al.. (2023). Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas. Neuro-Oncology Advances. 5(1). vdad087–vdad087. 4 indexed citations
2.
3.
Dudek, Arkadiusz Z., Li Liu, James H. Fischer, et al.. (2020). Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy. Breast Cancer Research and Treatment. 183(3). 617–627. 16 indexed citations
4.
Miller, Jennifer, et al.. (2015). The ethics and regulatory landscape of including vulnerable populations in pragmatic clinical trials. Clinical Trials. 12(5). 503–510. 49 indexed citations
5.
Lee, Jin Kyung, et al.. (2014). Human Placental Lactogen Induces CYP2E1 Expression via PI 3-Kinase Pathway in Female Human Hepatocytes. Drug Metabolism and Disposition. 42(4). 492–499. 14 indexed citations
6.
Fischer, James H., Gloria E. Sarto, Sarah J. Kilpatrick, et al.. (2011). Influence of Body Weight, Ethnicity, Oral Contraceptives, and Pregnancy on the Pharmacokinetics of Azithromycin in Women of Childbearing Age. Antimicrobial Agents and Chemotherapy. 56(2). 715–724. 20 indexed citations
7.
Hibbard, Judith U., et al.. (2010). Betamethasone in pregnancy: influence of maternal body weight and multiple gestation on pharmacokinetics. American Journal of Obstetrics and Gynecology. 203(3). 254.e1–254.e12. 29 indexed citations
8.
Fischer, James H., et al.. (2007). Effects of Lanthanum Carbonate on the Absorption and Oral Bioavailability of Ciprofloxacin. Clinical Journal of the American Society of Nephrology. 2(6). 1235–1240. 33 indexed citations
9.
Fischer, James H., et al.. (1997). Stability of Fosphenytoin Sodium with Intravenous Solutions in Glass Bottles, Polyvinyl Chloride Bags, and Polypropylene Syringes. Annals of Pharmacotherapy. 31(5). 553–559. 15 indexed citations
10.
11.
Marchetti, Albert, Raf Magar, James H. Fischer, Edward P. Sloan, & P Fischer. (1996). A pharmacoeconomic evaluation of intravenous fosphenytoin (Cerebyx®) versus intravenous phenytoin (Dilantin®) in hospital emergency departments. Clinical Therapeutics. 18(5). 953–966. 31 indexed citations
12.
Hariman, Robert J., et al.. (1994). Reversal of the Electrocardiographic Effects of Cocaine by Lidocaine. Part 2. Concentration‐Effect Relationships. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 14(6). 704–711. 17 indexed citations
13.
Fischer, James H., et al.. (1994). Gabapentin: A New Agent for the Management of Epilepsy. Annals of Pharmacotherapy. 28(10). 1188–1196. 47 indexed citations
14.
Fischer, James H., et al.. (1994). Lack of serious toxicity following gabapentin overdose. Neurology. 44(5). 982–982. 60 indexed citations
15.
Micali, Giuseppe, Giovanna Distéfano, L Caltabiano, et al.. (1993). Evaluation of Transdermal Theophylline Pharmacokinetics in Neonates. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 13(4). 386–390. 5 indexed citations
16.
Robinson, J. Daniel, et al.. (1993). Therapeutic Monitoring and Pharmacist Intervention in a Hansen's Disease Clinic. Annals of Pharmacotherapy. 27(12). 1526–1531. 5 indexed citations
17.
Rodvold, Keith A., Robert A. Blum, Louise J. Riff, et al.. (1989). Simulation of Vancomycin Peak and Trough Concentrations Using Five Dosing Methods in 37 Patients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 9(1). 10–16. 17 indexed citations
18.
Kriel, Robert L., et al.. (1986). Valproic acid pharmacokinetics in children: III. Very high dosage requirements. Pediatric Neurology. 2(4). 202–208. 29 indexed citations
19.
Cwik, Michael, et al.. (1985). Quantitative determination of tolazoline in serum and urine. Journal of Chromatography B Biomedical Sciences and Applications. 338(1). 123–130. 1 indexed citations
20.
Fischer, James H.. (1977). [Studies on the relationship of maturity to the tolerance of ischemia].. PubMed. 95(29). 1833–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John H. Cavanaugh Breakdown of academic impact, for papers by Kathleen D. Lake Breakdown of academic impact, for papers by Alfonso Carvajal Breakdown of academic impact, for papers by Daniel M. Canafax Breakdown of academic impact, for papers by Gary J. Muirhead Breakdown of academic impact, for papers by Gary L. Lensmeyer Breakdown of academic impact, for papers by Walter K. Kraft Breakdown of academic impact, for papers by Gideon Koren Breakdown of academic impact, for papers by E Hvidberg Breakdown of academic impact, for papers by María José García Sánchez
Rankless by CCL
2026